RVMD - Revolution Medicines Inc
IEX Last Trade
42.7
0.900 2.108%
Share volume: 717,465
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$41.80
0.90
2.15%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-07 | 2023-02-27 | 2023-05-08 | 2023-08-08 | 2023-11-06 | 2024-02-26 | 2024-05-08 | |
| Total revenue | 9.116 M | 3.356 M | 15.330 M | 7.014 M | 3.824 M | 0.000 | 742.000 K | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 9.116 M | 3.356 M | 15.330 M | 7.014 M | 3.824 M | 0.000 | 742.000 K | 0.000 | |
| -63.19% | 356.79% | -54.25% | -45.48% | -100.00% | inf% | -100.00% | |||
| Operating expenses | 71.205 M | 79.889 M | 77.038 M | 82.171 M | 112.621 M | 123.248 M | 180.725 M | 140.859 M | |
| Selling general and admin | 10.204 M | 10.434 M | 10.911 M | 13.224 M | 14.640 M | 15.513 M | 32.244 M | 22.838 M | |
| Research and development | 61.001 M | 69.455 M | 66.127 M | 68.947 M | 97.981 M | 107.735 M | 148.481 M | 118.021 M | |
| Total expenses | 71.205 M | 79.889 M | 77.038 M | 82.171 M | 112.621 M | 123.248 M | 180.725 M | 140.859 M | |
| 12.20% | -3.57% | 6.66% | 37.06% | 9.44% | 46.64% | -22.06% | |||
| Operating income | -62.089 M | -76.533 M | -61.708 M | -75.157 M | -108.797 M | -123.248 M | -179.983 M | -140.859 M | |
| Ebit | -62.089 M | -76.533 M | -61.708 M | -75.157 M | -108.797 M | -123.248 M | -179.983 M | -140.859 M | |
| Pretax income | -61.222 M | -73.626 M | -56.630 M | -68.098 M | -98.298 M | -112.301 M | -161.194 M | -116.003 M | |
| 20.26% | -23.08% | 20.25% | 44.35% | 14.25% | 43.54% | -28.04% | |||
| Income tax | 0.000 | -297.000 K | -123.000 K | 0.000 | 0.000 | -3.867 M | 343.000 K | 0.000 | |
| Net income basic | -61.222 M | -73.329 M | -56.507 M | -68.098 M | -98.298 M | -108.434 M | -161.537 M | -116.003 M | |
| -19.78% | 22.94% | -20.51% | -44.35% | -10.31% | -48.97% | 28.19% | |||
| Net income | -61.222 M | -73.329 M | -56.507 M | -68.098 M | -98.298 M | -108.434 M | -161.537 M | -116.003 M | |
| -19.78% | 22.94% | -20.51% | -44.35% | -10.31% | -48.97% | 28.19% |